Laerdal Million Lives Fund

About The Fund

Laerdal Million Lives Fund is an investment fund that specializes in seeding and nurturing businesses that offer innovative solutions across sectors such as HealthTech, Fitness, Medical Devices, Hospital Services, Healthcare, Wellness, and Consumer products. With a focus on Seed, Series A, and Series B funding stages, the fund aims to propel companies that can significantly improve and save a multitude of lives. Their investment strategy is characterized by a minimum fund injection of $1,000,000 and a maximum of $5,000,000, while their ‘sweet spot’ for investments typically revolves around $2,500,000. The fund’s team, led by Managing Partner Jeff Trost, is composed of experienced professionals who bring valuable insight and support to the healthcare industry. The investment team, with backgrounds across health technology, venture capital, investment banking, and management consulting, adds a broad spectrum of expertise to the fund. Additionally, through a network of Venture Advisors and Global Health Advisors like Tory Patterson, Trond Riiber Knudsen, Chelsea Clinton, and Andrew Farnum, Laerdal Million Lives Fund is equipped with diverse perspectives and deep knowledge in global health and technology. This network enhances their ability to identify potential breakthrough advancements and drive meaningful growth in their portfolio companies. The fund's strategy aligns with its mission to foster innovative solutions that can reach millions and offer measurable improvements in the quality of healthcare services, patient outcomes, and overall wellness across the globe, favoring ventures that demonstrate the promise of scale, sustainability, and a profound health impact.